Agilent Technologies Inc (A)
132.39
+0.33
(+0.25%)
USD |
NYSE |
Nov 22, 10:44
Agilent Technologies EPS Diluted (Quarterly): 0.97 for July 31, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | 0.97 |
| April 30, 2024 | 1.05 |
| January 31, 2024 | 1.18 |
| October 31, 2023 | 1.62 |
| July 31, 2023 | 0.38 |
| April 30, 2023 | 1.02 |
| January 31, 2023 | 1.19 |
| October 31, 2022 | 1.23 |
| July 31, 2022 | 1.10 |
| April 30, 2022 | 0.91 |
| January 31, 2022 | 0.93 |
| October 31, 2021 | 1.45 |
| July 31, 2021 | 0.86 |
| April 30, 2021 | 0.70 |
| January 31, 2021 | 0.93 |
| October 31, 2020 | 0.71 |
| July 31, 2020 | 0.64 |
| April 30, 2020 | 0.32 |
| January 31, 2020 | 0.63 |
| October 31, 2019 | 0.62 |
| July 31, 2019 | 0.60 |
| April 30, 2019 | 0.57 |
| January 31, 2019 | 1.57 |
| October 31, 2018 | 0.61 |
| July 31, 2018 | 0.73 |
| Date | Value |
|---|---|
| April 30, 2018 | 0.63 |
| January 31, 2018 | -0.99 |
| October 31, 2017 | 0.54 |
| July 31, 2017 | 0.54 |
| April 30, 2017 | 0.50 |
| January 31, 2017 | 0.52 |
| October 31, 2016 | 0.38 |
| July 31, 2016 | 0.38 |
| April 30, 2016 | 0.28 |
| January 31, 2016 | 0.36 |
| October 31, 2015 | 0.42 |
| July 31, 2015 | 0.33 |
| April 30, 2015 | 0.26 |
| January 31, 2015 | 0.19 |
| October 31, 2014 | 0.05 |
| July 31, 2014 | 0.43 |
| April 30, 2014 | 0.41 |
| January 31, 2014 | 0.58 |
| October 31, 2013 | 0.63 |
| July 31, 2013 | 0.49 |
| April 30, 2013 | 0.48 |
| January 31, 2013 | 0.51 |
| October 31, 2012 | 1.20 |
| July 31, 2012 | 0.69 |
| April 30, 2012 | 0.72 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
0.32
Minimum
Apr 2020
1.62
Maximum
Oct 2023
0.9379
Average
0.93
Median
Jan 2021
EPS Diluted (Quarterly) Benchmarks
| Bio-Rad Laboratories Inc | 23.34 |
| Bruker Corp | 0.27 |
| Azenta Inc | -0.10 |
| Harvard Bioscience Inc | -0.11 |
| Phibro Animal Health Corp | 0.17 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 282.00M |
| Revenue (Quarterly) | 1.578B |
| Total Expenses (Quarterly) | 1.245B |
| Enterprise Value | 39.10B |
| Gross Profit Margin (Quarterly) | 54.18% |
| Profit Margin (Quarterly) | 17.87% |
| Earnings Yield | 3.64% |
| Operating Earnings Yield | 3.83% |
| Normalized Earnings Yield | 3.641 |